Catherine Lomen‐Hoerth

Author

University of California, San Francisco ORCID

Also Known As

C. Lomen-Hoerth, Catherine Lomen-Hoerth, Catherine Lomen‐Hoerth, Catherine lomen-Hoerth, Lomen-Hoerth, Catherine, Sara Llufriu, Thomas Meyer

111

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Mayo Clinic in Florida Drexel University WinnMed Columbia University

About

Catherine Lomen‐Hoerth is an author at University of California, San Francisco specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	2.3K
2	Health Sciences	3	3	107
3	Social Sciences	3	3	297
4	Education	1	1	73
5	Public Health	1	1	52

Catherine Lomen‐Hoerth

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia Catherine Lomen‐Hoerth, Thomas Anderson, Bruce L. Miller Neurology Amyotrophic Lateral SclerosisMotor DysfunctionCorticobasal DegenerationNeurological DisorderDementia	2002	699
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease Sruti Rayaprolu, Bianca Mullen, Matt Baker, Molecular Neurodegeneration	2013	386
Comparison of family histories in FTLD subtypes and related tauopathies Jill Goldman, Jennifer Farmer, Elisabeth McCarty Wood, Neurology Family MedicineCorticobasal DegenerationGeneticsGenetic EpidemiologyFamily Histories	2005	346
Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis Travis Dunckley, Matthew J. Huentelman, David W. Craig, New England Journal of Medicine	2007	237
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Annals of Neurology	2009	233
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Vera Bril, Artur Drużdż, Julian Großkreutz, The Lancet Neurology Clinical TrialsGeneralised Myasthenia GravisPharmacotherapyMedicineAnesthesiology	2023	227
Continuum of Frontal Lobe Impairment in Amyotrophic Lateral Sclerosis Jennifer Murphy, Roland G. Henry, Susan E. Langmore, Archives of Neurology	2007	211
Tissue-specific alternative splicing generates two isoforms of the trkA receptor Philip Barker, Catherine Lomen‐Hoerth, Erin Gensch, Journal of Biological Chemistry Rna SplicingCellular PhysiologySplicing VariantTranscriptional RegulationSignaling Pathway	1993	204
Ataxin-2 repeat-length variation and neurodegeneration Owen A. Ross, Nicola J. Rutherford, Matthew Baker, Human Molecular Genetics GeneticsGlutamine RepeatsDisease Gene IdentificationSocial SciencesDegenerative Pathology	2011	171
Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis John Ravits, Stanley H. Appel, Robert H. Baloh, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Neurodegenerative DiseasesProgressive Muscular AtrophyAmyotrophic Lateral SclerosisSporadic AlsNeurological Disorder	2013	166

Page 1